Managing Partner

Noida

+91 120 4059300

Elite Practitioner


Jurisdiction:

India

Practice area:

Intellectual property

Industry sectors:

Pharmaceuticals and life sciences
Technology and telecommunications


Pravin Anand is a pre-eminent IP lawyer. Awarded the AIPPI Award of Merit, INTA’s President’s Award and recognised the “Most Innovative Lawyer” for Asia Pacific by Financial Times, Pravin has appeared in 2500 plus cases in over 42 years' practice as an IP lawyer.

Author of ‘Halsbury’s Laws of India on Intellectual Property’ and a large number of Chapters in International IP Publications, Pravin has been spreading the message of IP outside courts with:

  • The Raj Anand Moot Court Competition since 1997
  • ‘Anaryst’ – an IP Board Game
  • ‘Brainchild - First IP-themed play
  • ‘Adventures of Mr. IP’ – an IP Comic
  • ‘IPONOMICS’ – a Coffee Table Book

RECENT PROFESSIONAL HONOURS:

  • INTA President’s Award 2021
  • Ranked amongst Top 15 IP lawyers in Asia and Top IP lawyers in India by Thomson Reuters Asian Legal Business
  • Ranked as "Though leader" in IP Patents, Trademarks and Life Sciences in Who's Who Legal 2022 edition
  • Managing Partner of the Year - Asian Legal Business India Law Awards 2021
  • Patent Lawyer of the Year - Legal Era India Legal Awards 2021
  • Leading IP lawyers of the Decade - Legal Era India law Awards 2020
  • Managing Intellectual Property IP Star - Patent 2017-21
  • Chambers and Partners Top Ranked lawyer in IP Litigation and Life Sciences - 2017-22
  • Benchmark Litigation Asia Pacific Dispute Resolution Star 2021
  • World’s Leading Practitioners - IAM Patent 1000 (2016-21)
  • World’s Leading IP Strategists - IAM Strategy 300 (2016-21)
  • Inducted in Legal 500 Hall of Fame

  • Competition/antitrust
  • Dispute resolution
  • Intellectual property

  • Vifor International v MSN Labs & Ors – India’s first judgement on Product-by-Process Patent
  • Nokia v Oppo – India’s first protem security order
  • InterDigital v Xiaomi – India’s first Anti-Anti suit injunction (read more)
  • Patent lawsuits transforming Indian pharmaceutical and bio-technology enforcement regime-Merck Vs. Glenmark;Roche Vs. Cipla;the Monsanto case; large number of suits on behalf of Pfizer, BMS, AstraZeneca, etc.
  • India’s Ist Anti-anti-suit injunction (InterDigital v Xiaomi)
  • Nokia-Lenovo multi-tech, multi-year settlement;
  • India’s first lawsuit conferring protection to ICT software (Ferid Allani case);
  • Development of damages culture in cases recognizing compensatory, exemplary and aggravated damages (Philips Vs. AmazeStore);
  • India’s first post-trial SEP judgment; unique remedies such as “Tree Planting Order” (Merck case); and order benefitting adolescent girls (Hermes case).

  • Consumer goods and services
  • Pharmaceuticals and life sciences
  • Media and entertainment
  • Technology and telecommunications
  • Industrials and manufacturing

  • APAA
  • AIPPI
  • INTA